Vision Without Turbulence

Head in the clouds? Good. That’s where some of the best ideas live.
We help you navigate biotech strategy from high-level vision to ground-level execution.

Getting to IND … CatalyzeBio takes preclinical companies to IND, bringing decades of hard-won experience in drug development, project management and partnerships to help bring your vision to reality.

How We Work With You

Discovery Call

A focused conversation to understand where you are, where you want to go, and whether we’re the right partner to get you there.

Diagnostic

A deep-dive assessment of your project, data, and goals — identifying gaps, risks, and opportunities before any strategy is built.

Project Roadmap

A tailored roadmap outlining our recommended approach, scope, and next steps, grounded in what the Diagnostic and our conversation revealed.

Ongoing Support

Depending on the company, the ongoing support may differ.

What We Do

CatalyzeBio+logo1+1024x1024_ORANGE_rect_f8f1eb_crop

Startup Formation

Does your value proposition get attention? Do you have the needed skills or do you need to augment your team? Is your IP position defensible? Development pathway? Which approach to equity allocation is best for you? We can help.

Business Development

Growing your business requires competitive intelligence and strategic partnerships … we help you negotiate licenses, set up collaboration and research agreements, and provide due diligence on in-licensing arrangements. We are also experienced in outreach to and for nonprofits.

Project De-Risking

Great ideas are at risk unless both the scientific foundations and their intellectual property status has been evaluated. Our scientific due diligence can help mitigate risks and identify new opportunities for business growth.

R&D Strategy and Planning

How will you get from concept to clinic? Is your pre-clinical plan on track to an IND? Can you justify your lab work to stakeholders and investors? What key experiments will take you to the next stage of the value chain? We’ll help you craft a strategy to address all these points.

Who We Are

We bring International corporate experience as well as deep academic and institution background covering many modalities of biotechnology and biotherapeutics.

Dr. Raymond Oomen, Ph.D. trained in protein chemistry and molecular immunology before a 30-year career in industry. He founded the global bioinformatics and genomics platform at Sanofi Pasteur pioneering structure-based antigen design and inventing several vaccine candidates that went to clinical trial. As VP of Infectious Disease Therapeutics at Emergent BioSolutions, he was responsible for vaccine and mAb projects. Subsequently, he was invited to take on the CEO role at a biotechnology commercialization acceleration firm and contributed as founding CSO to the creation of a stealth startup in AI-enabled protein design.

Dr. Jahan Ali works with biotech founders to move their companies forward — drawing on 25 years spent building biotech companies from the inside, negotiating partnerships, investing in early-stage ventures, and designing the programs that help founders reach their next milestone.

She has negotiated a wide range of agreements, including in- and out-licensing, research collaborations, manufacturing agreements, and stock purchase agreements — experience built across roles as Director of Business Development at the International AIDS Vaccine Initiative, a licensing professional at the Hospital for Special Surgery and Mount Sinai, and life science investment lead at the Partnership Fund, a private fund founded by Henry Kravis.

At the Bioventure eLab at Weill Cornell, she built an investor conference, mentorship program, and startup competitions for founders. At SymBiosis Capital, she secured a multi-million-dollar commitment from investors to grow the regional life science ecosystem.

Today, she helps companies develop and execute their plans to get to IND.

Reach out for a Discovery Call and let’s explore the possibilities together.